Cardiac Guidance vs FFRangio System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardiac Guidance

by Caption Health

FFRangio System

by CathWorks (acquired by Medtronic)

AI Verdict

Tool A, Cardiac Guidance, focuses on democratizing cardiac ultrasound acquisition and interpretation at the point of care for general cardiac assessments. Tool B, FFRangio System, provides wire-free FFR guidance for optimizing percutaneous coronary intervention (PCI) decisions in patients with coronary artery disease within a cath lab setting. While both leverage AI in cardiology, they address distinct diagnostic and interventional needs using different imaging modalities.

Choose Cardiac Guidance if…

Choose Cardiac Guidance if your primary objective is to empower a broader range of healthcare professionals, including those without extensive echocardiography expertise, to acquire diagnostic-quality cardiac ultrasound images at the point of care. This tool is ideal for settings focused on democratizing access to early cardiac assessments and improving diagnostic capabilities outside of traditional cardiology departments.

View Cardiac Guidance →

Choose FFRangio System if…

Choose the FFRangio System if you are an interventional cardiologist requiring precise, wire-free, and drug-free functional assessment of coronary artery disease to optimize and confirm PCI decisions within the cath lab. This system is best suited for scenarios where real-time, multi-vessel FFR guidance and advanced insights are needed to streamline interventional procedures and enhance patient outcomes.

View FFRangio System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardiac Guidance	FFRangio System
Pricing	Unknown	Contact vendor for pricing information.
Deployment	Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care.	SaaS, on-prem, hybrid
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiac Guidance

Cardiac Guidance is specifically designed to enable non-expert ultrasound users to acquire diagnostic-quality images through real-time, turn-by-turn guidance, significantly broadening its user base and simplifying a complex task. While FFRangio has an intuitive interface, it operates within a specialized cath lab setting for expert users.

Clinical Value

FFRangio System

The FFRangio System offers a significant clinical advantage by providing a non-invasive, AI-driven alternative to traditional invasive FFR, directly optimizing PCI decisions and reducing procedural risks for patients with coronary artery disease. While Cardiac Guidance democratizes diagnostic access, FFRangio's impact on treatment efficacy and patient safety in interventional cardiology is arguably more profound.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information, making it impossible to compare their cost-effectiveness or overall value proposition without specific financial details. Neither provides transparent pricing on their public specifications.

Enterprise Readiness

Cardiac Guidance

Cardiac Guidance explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for enterprise adoption in the US healthcare system. While FFRangio has strong certifications like ISO 27001 and robust integration capabilities, its HIPAA and BAA status is less explicitly confirmed in the provided data.

Innovation

FFRangio System

The FFRangio System's innovation in providing a completely non-invasive, AI-driven alternative to a traditionally invasive FFR procedure for coronary artery disease represents a more transformative shift in clinical practice. While Cardiac Guidance innovates in democratizing ultrasound, FFRangio's approach fundamentally changes a diagnostic pathway.

Support & Docs

Cardiac Guidance

Cardiac Guidance provides more direct and immediate access to its operator's manual and instructions for use directly within the software application or companion app. In contrast, accessing the FFRangio System's IFU requires a request and review process.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardiac Guidance	FFRangio System
Product Name	Cardiac Guidance	FFRangio System
Company	Caption Health	CathWorks
Tagline	AI-Guided Ultrasound for Early Disease Detection and Accessible Cardiac Care	A New Era in Coronary Physiology
Primary Clinical Application / Core Functionality	Real-time AI guidance for cardiac ultrasound image acquisition, automated quality assessment, auto-capture of diagnostic-quality images, and automated left ventricular ejection fraction (EF) calculation. Supports 10 standard echocardiographic views and is designed for non-expert ultrasound users.	Wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to optimize and confirm PCI decisions. Features real-time FFRangio values, simulated pullback curves, lesion impact assessment, and an integrated sizing tool.
Target Specialties	Cardiology, Emergency Medicine, Radiology	Cardiology

Videos

Demos, reviews, and walkthroughs featuring Cardiac Guidance and FFRangio System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the core clinical problem each tool addresses?

Cardiac Guidance (Tool A) helps healthcare professionals acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, democratizing access to critical cardiac assessments for early disease detection. FFRangio System (Tool B) provides wire-free and drug-free 3D FFR guidance to optimize and confirm PCI decisions for patients with coronary artery disease.

Who is the intended user and in what clinical setting is each tool primarily used?

Cardiac Guidance is designed for use by non-expert ultrasound users and other healthcare professionals in specialties like Cardiology, Emergency Medicine, and Radiology, typically at the point of care. The FFRangio System is intended for cardiologists in the cath lab, integrating with existing cath lab equipment and C-arm angiography systems to aid in coronary artery disease management.

How do these tools impact the invasiveness of cardiac procedures?

Cardiac Guidance is a non-invasive tool that uses AI-guided ultrasound to acquire images, making cardiac assessments more accessible without invasive procedures. The FFRangio System eliminates the need for invasive pressure wires, drugs, or a guide catheter during angiography, thereby reducing the invasiveness of FFR assessment in the cath lab.

What specific diagnostic or decision-making insights does each tool provide?

Cardiac Guidance offers real-time AI guidance for image acquisition, automated quality assessment, auto-capture of diagnostic images, and automated left ventricular ejection fraction (EF) calculation. The FFRangio System provides real-time FFRangio values at every point on the coronary tree, a simulated pullback curve to differentiate functional patterns of CAD, and a Lesion Impact feature to assess residual ischemia.